Trial Outcomes & Findings for Postoperative Acute Myocardial Ischemic Injury (NCT NCT02993263)
NCT ID: NCT02993263
Last Updated: 2022-01-11
Results Overview
Accuracy of VectraplexECG System with CEB
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
323 participants
Primary outcome timeframe
1 minute to complete the test
Results posted on
2022-01-11
Participant Flow
Recruitment process started by screening patients who are scheduled for non cardiac surgery. These patients are approached during their anesthesia clearance visit.
Open label study
Participant milestones
| Measure |
Noncardiac Surgery
VectraplexECG System with CEB® used after surgery and on day 1, 2, and 3 postoperatively
|
|---|---|
|
Overall Study
STARTED
|
323
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
323
|
Reasons for withdrawal
| Measure |
Noncardiac Surgery
VectraplexECG System with CEB® used after surgery and on day 1, 2, and 3 postoperatively
|
|---|---|
|
Overall Study
Equipment Software failed and results were lost.
|
323
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Noncardiac Surgery
n=323 Participants
VectraplexECG System with CEB® used after surgery and on day 1, 2, and 3 postoperatively
|
|---|---|
|
Age, Continuous
|
62.9 years
STANDARD_DEVIATION 9.3 • n=323 Participants
|
|
Sex: Female, Male
Female
|
164 Participants
n=323 Participants
|
|
Sex: Female, Male
Male
|
159 Participants
n=323 Participants
|
PRIMARY outcome
Timeframe: 1 minute to complete the testPopulation: Data were not collected, because of the malfunction of the equipment software failed.
Accuracy of VectraplexECG System with CEB
Outcome measures
Outcome data not reported
Adverse Events
Noncardiac Surgery
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place